Complete hematologic response after belinostat treatment and allogeneic stem cell transplantation for multiple relapsed/refractory angioimmunoblastic T-cell lymphoma: A case report

被引:1
|
作者
Camus, Vincent [1 ,5 ]
Etancelin, Pascaline [2 ]
Drieux, Fanny [3 ]
Veresezan, Elena-Liana [3 ]
Picquenot, Jean-Michel [3 ]
Penther, Dominique [2 ]
Viennot, Mathieu [4 ]
Ruminy, Philippe [4 ]
Contentin, Nathalie [1 ]
Lemasle, Emilie [1 ]
Lepretre, Stephane [1 ]
Dubois, Sydney [1 ]
Penichoux, Juliette [1 ]
Stamatoullas, Aspasia [1 ]
Zduniak, Alexandra [1 ]
Lanic, Helene [1 ]
Jardin, Fabrice [1 ]
机构
[1] Ctr Henri Becquerel, Dept Hematol, Rouen, France
[2] Ctr Henri Becquerel, Dept Genet Oncol, Rouen, France
[3] Ctr Henri Becquerel, Dept Pathol, Rouen, France
[4] Ctr Henri Becquerel, INSERM U1245, Rouen, France
[5] Ctr Henri Becquerel, Dept Hematol, Rue Amiens, F-76038 Rouen 1, France
来源
CLINICAL CASE REPORTS | 2023年 / 11卷 / 06期
关键词
allogenic stem cell transplantation; belinostat; complete response; HDAC inhibitor; nTFHL-AI; PTCL;
D O I
10.1002/ccr3.7623
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Key Clinical MessageThis case report highlights the potential of belinostat for the treatment of relapsed/refractory peripheral T-cell lymphomas, for which effective therapies are still scarce. Peripheral T-cell lymphomas have an aggressive disease course associated with poor outcomes. We report a young patient with highly pretreated relapsed/refractory nodal follicular helper T-cell lymphoma (angioimmunoblastic-type [nTFHL-AI]), who successfully received an allogeneic stem cell transplantation following belinostat therapy. The complete hematologic response achieved has lasted more than 2 years.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma
    Li, Meng
    Gao, Chunji
    Li, Honghua
    Wang, Zhihong
    Cao, Yongbin
    Huang, Wenrong
    Li, Xiaohong
    Wang, Shuhong
    Yu, Li
    Da, Wanming
    MEDICAL ONCOLOGY, 2011, 28 (03) : 840 - 845
  • [22] Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report
    Tanaka, Ken
    Miyoshi, Hiroaki
    Yamashita, Yusuke
    Iwamoto, Ryuta
    Yokoya, Yuma
    Tochino, Yuichi
    Arakawa, Fumiko
    Tamura, Shinobu
    Murata, Shin-Ichi
    Sonoki, Takashi
    Ohshima, Koichi
    HEMATOLOGY REPORTS, 2023, 15 (04) : 662 - 669
  • [23] Allogeneic stem cell transplantation for refractory cutaneous T-cell lymphoma (CTCL).
    Oyama, Y
    Burt, RK
    Kuzel, T
    Traynor, AE
    Rosen, S
    BLOOD, 2001, 98 (11) : 379B - 379B
  • [24] Therapeutic effect of chidamide on relapsed refractory angioimmunoblastic T-cell lymphoma A case report and literature review
    Jin, Jingxia
    Zheng, Cuiping
    Wu, Shenghao
    MEDICINE, 2018, 97 (02)
  • [25] Allogeneic stem cell transplantation as treatment for relapsed and high-risk peripheral T-cell lymphoma
    O'Leary, Hilary M.
    Savage, Kerry J.
    Toze, Cynthia L.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Abou Mourad, Yasser
    Barnett, Michael J.
    Forrest, Donna L.
    Hogge, Donna E.
    Lavoie, Julye
    Nantel, Stephen H.
    Nevill, Thomas J.
    Shepherd, John D.
    Smith, Clayton
    Sutherland, Heather J.
    Voss, Nicholas
    Brinkmann, Ryan
    Song, Kevin
    BLOOD, 2007, 110 (11) : 893A - 893A
  • [26] Refractory T-cell Cutaneous Lymphoma Treated with Allogeneic Haploidentic Hematopoietic Stem Cell Transplantation- A Case Report
    Silva, Marcia
    Laso, Natalia
    Moreira, Maria Claudia
    Lermontov, Simone
    Barbosa, Rita De Cassia
    Maradei, Simone
    Colares, Marta
    Gonzaga, Yung
    Arcuri, Leonardo
    Araujo, Renato
    Lerner, Decio
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 431 - 431
  • [27] DIFFICULT TREATMENT PATHWAY IN A RELAPSED AND REFRACTORY HODGKIN LYMPHOMA CASE: ALLOGENEIC STEM CELL TRANSPLANTATION
    Karadurmus, N.
    Yildiz, B.
    Erturk, I.
    Ozaydin, S.
    LEUKEMIA RESEARCH, 2016, 49 : S49 - S50
  • [28] Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Treatment for Relapsed or Refractory Lymphoma
    Wang, Jing-Shi
    Wang, Zhao
    Wang, Yi-Ni
    Wu, Lin
    Fu, Li
    Wei, Na
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2015, 31 (04) : 426 - 433
  • [29] Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Treatment for Relapsed or Refractory Lymphoma
    Jing-Shi Wang
    Zhao Wang
    Yi-Ni Wang
    Lin Wu
    Li Fu
    Na Wei
    Indian Journal of Hematology and Blood Transfusion, 2015, 31 : 426 - 433
  • [30] Allogeneic Stem Cell Transplantation in Refractory/Relapsed Lymphoma Patients
    Kapoor, Jyotsna
    Agrawal, Narendra
    Mehta, Pallavi
    Ahmed, Rayaz
    Bhurani, Dinesh
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S252 - S253